- 02.11.20152015 Northwestern Scleroderma Program Newsletter
- 02.10.2015Dartmouth Investigators Identify Key Pathways Underlying Different Subsets of Systemic Sclerosis
- 02.09.2015Fat Tissue May Be Key to Scleroderma's Progression
About the Program
Scleroderma is a progressive autoimmune disease that can cause stiffening and scarring of the skin, lungs, kidneys, blood vessels, and other organs. Our program pursues intensive basic and clinical research to advance the treatment of scleroderma. Our work requires the collaboration of many specialists, including rheumatology, pulmonary, dermatology, cardiology, nephrology, gastroenterology, and plastic surgery.
The Northwestern Scleroderma Program is committed to conducting innovative research to increase our knowledge of the disease, allowing us to provide advanced, individualized patient care at Feinberg-affiliated care sites.